share_log

BTIG Maintains Buy on Adaptive Biotechnologies, Lowers Price Target to $5

Moomoo 24/7 ·  Apr 4 11:18

BTIG analyst Mark Massaro maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and lowers the price target from $6 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment